| Mrs Danelle Lynn Morrow, MS, CCC-SLP | |
|
2085 Wayne Rd, Chambersburg, PA 17202-8586 | |
| (717) 709-0668 | |
| Not Available |
| Full Name | Mrs Danelle Lynn Morrow |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2085 Wayne Rd, Chambersburg, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366694002 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL008156 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Danelle Lynn Morrow, MS, CCC-SLP 6269 Duffield Rd, Chambersburg, PA 17202-8435 Ph: (412) 418-1706 | Mrs Danelle Lynn Morrow, MS, CCC-SLP 2085 Wayne Rd, Chambersburg, PA 17202-8586 Ph: (717) 709-0668 |
News Archive
Oncothyreon Inc. (NASDAQ: ONTY) (TSX: ONY) today reported a net loss of $6.3 million, or $0.30 per basic and diluted share, for the three months ended June 30, 2009, compared with a net loss of $4.9 million, or $0.25 per basic and diluted share, for the comparable period in 2008.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced data on ZGN-201, a prototype methionine aminopeptidase 2 inhibitor, for the treatment of obesity. Preclinical studies demonstrate MetAP2 inhibition eliminates excess body weight through the regulation of fat metabolism and food intake, and normalizes glucose tolerance in animal models.
Alissa Fox, vice president of legislative and regulatory policy for the Blue Cross and Blue Shield Association, on Friday said that additional reductions in reimbursements to private Medicare Advantage plans "would be a disaster" for the program, CQ HealthBeat reports.
Patients with severely injured limbs often suffer a devastating loss of sensation. The implants, called "nerve guidance conduits" or NGCs were produced by British and German engineers with a laser technique normally used to write complex electrical circuits. Made from a form of biodegradable plastic, they guide regrowing nerve fibres through individual channels to aid recovery. Once the nerves are fully regrown and reconnected, the device dissolves away.
› Verified 1 days ago
Katelyn Mcanlis, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 820 5th Ave, Chambersburg, PA 17201 Phone: 717-709-7920 | |
Carah Boyer, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 32 Parkwood Dr, Chambersburg, PA 17201 Phone: 717-446-0439 | |
Laurie Anne Kaufman, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 820 5th Ave, Chambersburg, PA 17201 Phone: 717-709-7920 Fax: 717-263-6922 | |
Olivia Lucienne Aloisi, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 111 Chambers Hill Dr Ste 101, Chambersburg, PA 17201 Phone: 717-709-7997 | |
Mr. Ian H Jones, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-267-7718 | |
Marsha A Munson, SLPL Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1648 Alexander Ave, Chambersburg, PA 17201 Phone: 717-263-3440 |